Analyze Diet

Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety.

Abstract: This study was designed to evaluate whether Lactobacillus rhamnosus strain GG (LGG), an extensively studied probiotic organism in humans, can colonize the intestines of adult horses and foals. Lactobacillus rhamnosus strain GG was administered to adult horses at doses of 1 x 10(9) CFU/50kg bodyweight (BW)/day (group 1, 7 horses), 1 x 10(10) colony forming units/ 50kg BW/day (group 2, 7 horses) and 5 x 10(10) colony forming units/50kg BW/day (group 3, 7 horses) for 5 d. Foals received 2 x 10(10) colony forming units/50kg BW/day (group 1, 7 foals) or 1 x 10(11) colony forming units/50kg BW/day (group 2, 7 foals) for 5 d. Fecal levels of L. rhamnosus strain GG in adult horses were low and variable in the 2 lower dose groups. Even in the high dose group, colonization was relatively low. In contrast, more consistent intestinal colonization was present in foals, and colonization persisted for up to 9 d following cessation of administration. No adverse effects were observed in any animal. Clinical studies evaluating this probiotic are indicated in foals. The presence of this organism in the feces of adult horses may only represent passive movement through the intestinal tract, not actual colonization. Consistent intestinal colonization in adults was only achieved with a prohibitively high dose.
Publication Date: 2003-04-29 PubMed ID: 12715981PubMed Central: PMC372248
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the effectiveness and safety of administering a probiotic strain, Lactobacillus rhamnosus, to adult horses and foals, and its ability to colonize in the intestines.

Study Design and Methodology

  • The study involves the administration of different dosages of Lactobacillus rhamnosus strain GG (LGG) to adult horses and foals. Three groups of adult horses received 1 x 10(9), 1 x 10(10), and 5 x 10(10) colony forming units (CFU) of probiotics per 50kg bodyweight per day respectively. Two groups of foals received 2 x 10(10) and 1 x 10(11) CFU per 50kg bodyweight per day respectively. These doses were given for a period of 5 days.
  • The primary focus was to measure fecal recovery of L. rhamnosus GG after oral administration. The presence of the probiotic strain in feces was monitored and analyzed to measure the level of colonization in the intestines.

Results and Findings

  • For adult horses, the findings show low and irregular levels of LGG in the feces for the two lower dose groups. Even at the high dose, colonization was relatively low, suggesting that LGG might have difficulty colonizing the intestines of adult horses. The presence of LGG in fecal matter might only represent passive movement through the intestinal tract, instead of actual colonization.
  • In contrast, the foals had a more consistent intestinal colonization. Furthermore, they could retain colonization for up to nine days after the last dosage, suggesting a more compatible relationship between the probiotic strain and the digestive environment of foals.
  • It’s important to note that no adverse, or harmful, effects were observed in any of the horses during the course of the study. This adds on to the evidence of the safety profile of LGG for usage in horses.

Conclusion and Recommendations

  • The results suggest that LGG may have more probiotic potential in foals compared to adult horses, due to the more consistent colonization observed. More clinical studies are recommended to support this finding and gauge its potential benefits.
  • Adult horses may require prohibitively high doses for LGG to achieve consistent intestinal colonization, which may not be practical or feasible in real-world applications.

Cite This Article

APA
Weese JS, Anderson ME, Lowe A, Monteith GJ. (2003). Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety. Can Vet J, 44(4), 299-302.

Publication

ISSN: 0008-5286
NlmUniqueID: 0004653
Country: Canada
Language: English
Volume: 44
Issue: 4
Pages: 299-302

Researcher Affiliations

Weese, J Scott
  • Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1. jsweese@uoguelph.ca
Anderson, Maureen E C
    Lowe, Andrew
      Monteith, Gabrielle J

        MeSH Terms

        • Administration, Oral
        • Animals
        • Animals, Newborn
        • Bacterial Adhesion
        • Colony Count, Microbial / veterinary
        • Digestive System / microbiology
        • Feces / microbiology
        • Horse Diseases / prevention & control
        • Horses / microbiology
        • Lactobacillus / growth & development
        • Lactobacillus / physiology
        • Probiotics / administration & dosage
        • Probiotics / therapeutic use
        • Random Allocation
        • Safety

        References

        This article includes 30 references
        1. Guarner F, Schaafsma GJ. Probiotics.. Int J Food Microbiol 1998 Feb 17;39(3):237-8.
          pubmed: 9553803doi: 10.1016/s0168-1605(97)00136-0google scholar: lookup
        2. Metchnikoff E. The Prolongation of Life. London. William Heinemann 1907.
        3. Reid G. In defense of probiotics. ASM News 2000;66:261.
        4. Parraga ME, Spier SJ, Thurmond M, Hirsh D. A clinical trial of probiotic administration for prevention of Salmonella shedding in the postoperative period in horses with colic.. J Vet Intern Med 1997 Jan-Feb;11(1):36-41.
        5. Kim LM, Morley PS, Traub-Dargatz JL, Salman MD, Gentry-Weeks C. Factors associated with Salmonella shedding among equine colic patients at a veterinary teaching hospital.. J Am Vet Med Assoc 2001 Mar 1;218(5):740-8.
          pubmed: 11280409doi: 10.2460/javma.2001.218.740google scholar: lookup
        6. Fuller R. Probiotics in human medicine.. Gut 1991 Apr;32(4):439-42.
          pmc: PMC1379087pubmed: 1902810doi: 10.1136/gut.32.4.439google scholar: lookup
        7. Filho-Lima JV, Vieira EC, Nicoli JR. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice.. J Appl Microbiol 2000 Mar;88(3):365-70.
        8. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.. JAMA 1994 Jun 22-29;271(24):1913-8.
          pubmed: 8201735
        9. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F, Collins JK. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings.. Am J Clin Nutr 2001 Feb;73(2 Suppl):386S-392S.
          pubmed: 11157346doi: 10.1093/ajcn/73.2.386sgoogle scholar: lookup
        10. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.. Immunol Cell Biol 2000 Feb;78(1):80-8.
        11. Ouwehand AC, Niemi P, Salminen SJ. The normal faecal microflora does not affect the adhesion of probiotic bacteria in vitro.. FEMS Microbiol Lett 1999 Aug 1;177(1):35-8.
        12. Gorbach SL. Probiotics and gastrointestinal health.. Am J Gastroenterol 2000 Jan;95(1 Suppl):S2-4.
          pubmed: 10634218doi: 10.1016/s0002-9270(99)00806-0google scholar: lookup
        13. Gibson GR, Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use.. J Nutr 2000 Feb;130(2S Suppl):391S-395S.
          pubmed: 10721913doi: 10.1093/jn/130.2.391sgoogle scholar: lookup
        14. Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties.. J Biotechnol 2000 Dec 28;84(3):197-215.
          pubmed: 11164262doi: 10.1016/s0168-1656(00)00375-8google scholar: lookup
        15. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.. Dig Dis Sci 1992 Jan;37(1):121-8.
          pubmed: 1728516doi: 10.1007/bf01308354google scholar: lookup
        16. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption.. Appl Environ Microbiol 1999 Jan;65(1):351-4.
          pmc: PMC91031pubmed: 9872808doi: 10.1128/aem.65.1.351-354.1999google scholar: lookup
        17. Saxelin M, Ahokas M, Salminen S. Dose response on the faecal colonisation of Lactobacillus strain GG administered in two different formulations. Microbiol Ecol Health Dis 1993;6:119–122.
        18. Saxelin M, Elo S, Salminen S, Vapaatalo H. Dose response colonisation of faeces after oral administration of Lactobacillus casei strain GG. Microbiol Ecol Health Dis 1991;4:209–214.
        19. Armuzzi A, Cremonini F, Ojetti V, Bartolozzi F, Canducci F, Candelli M, Santarelli L, Cammarota G, De Lorenzo A, Pola P, Gasbarrini G, Gasbarrini A. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.. Digestion 2001;63(1):1-7.
          pubmed: 11173893doi: 10.1159/000051865google scholar: lookup
        20. Oberhelman RA, Gilman RH, Sheen P, Taylor DN, Black RE, Cabrera L, Lescano AG, Meza R, Madico G. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children.. J Pediatr 1999 Jan;134(1):15-20.
          pubmed: 9880443doi: 10.1016/s0022-3476(99)70366-5google scholar: lookup
        21. Saavedra J. Probiotics and infectious diarrhea.. Am J Gastroenterol 2000 Jan;95(1 Suppl):S16-8.
          pubmed: 10634223doi: 10.1016/s0002-9270(99)00811-4google scholar: lookup
        22. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children.. J Pediatr 1999 Nov;135(5):564-8.
          pubmed: 10547243doi: 10.1016/s0022-3476(99)70053-3google scholar: lookup
        23. Oksanen PJ, Salminen S, Saxelin M, Hämäläinen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, Nikkari S, Oksanen T, Pörsti I, Salminen E. Prevention of travellers' diarrhoea by Lactobacillus GG.. Ann Med 1990 Feb;22(1):53-6.
          pubmed: 2184847doi: 10.3109/07853899009147242google scholar: lookup
        24. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S, Massar K, Micetic-Turk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska H, Weizman Z. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial.. J Pediatr Gastroenterol Nutr 2000 Jan;30(1):54-60.
        25. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan.. Pediatr Infect Dis J 1995 Feb;14(2):107-11.
        26. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children.. Pediatrics 1991 Jul;88(1):90-7.
          pubmed: 1905394
        27. Lee DJ, Drongowski RA, Coran AG, Harmon CM. Evaluation of probiotic treatment in a neonatal animal model.. Pediatr Surg Int 2000;16(4):237-42.
          pubmed: 10898221doi: 10.1007/s003830050736google scholar: lookup
        28. Saxelin M, Pessi T, Salminen S. Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers.. Int J Food Microbiol 1995 Apr;25(2):199-203.
          pubmed: 7547151doi: 10.1016/0168-1605(94)00091-jgoogle scholar: lookup
        29. Anonymous. SAS/STAT Software: changes and enhancements through release 6.12. Cary, North Carolina, USA.
        30. Campbell ML, Ackerman N, Peyton LC. Radiographic gastrointestinal anatomy of the foal. Vet Radiol 1984;25:194–204.

        Citations

        This article has been cited 12 times.
        1. MacNicol JL, Renwick S, Ganobis CM, Allen-Vercoe E, Weese JS, Pearson W. The influence of a probiotic/prebiotic supplement on microbial and metabolic parameters of equine cecal fluid or fecal slurry in vitro.. J Anim Sci 2023 Jan 3;101.
          doi: 10.1093/jas/skad034pubmed: 36715114google scholar: lookup
        2. Goodman-Davis R, Figurska M, Cywinska A. Gut Microbiota Manipulation in Foals-Naturopathic Diarrhea Management, or Unsubstantiated Folly?. Pathogens 2021 Sep 4;10(9).
          doi: 10.3390/pathogens10091137pubmed: 34578169google scholar: lookup
        3. Freccero F, Lanci A, Mariella J, Viciani E, Quercia S, Castagnetti A, Castagnetti C. Changes in the Fecal Microbiota Associated with a Broad-Spectrum Antimicrobial Administration in Hospitalized Neonatal Foals with Probiotics Supplementation.. Animals (Basel) 2021 Aug 2;11(8).
          doi: 10.3390/ani11082283pubmed: 34438741google scholar: lookup
        4. Walshe N, Mulcahy G, Hodgkinson J, Peachey L. No Worm Is an Island; The Influence of Commensal Gut Microbiota on Cyathostomin Infections.. Animals (Basel) 2020 Dec 5;10(12).
          doi: 10.3390/ani10122309pubmed: 33291496google scholar: lookup
        5. Berreta A, Baumgardner RM, Kopper JJ. Evaluation of commercial veterinary probiotics containing enterococci for transferrable vancomycin resistance genes.. BMC Res Notes 2020 Jun 4;13(1):275.
          doi: 10.1186/s13104-020-05114-1pubmed: 32498700google scholar: lookup
        6. Bland SD, Venable EB, McPherson JL, Atkinson RL. Effects of liposomal-curcumin on five opportunistic bacterial strains found in the equine hindgut - preliminary study.. J Anim Sci Technol 2017;59:15.
          doi: 10.1186/s40781-017-0138-4pubmed: 28638626google scholar: lookup
        7. Rodriguez-Palacios A, Staempfli HR, Weese JS. High Doses of Halotolerant Gut-Indigenous Lactobacillus plantarum Reduce Cultivable Lactobacilli in Newborn Calves without Increasing Its Species Abundance.. Int J Microbiol 2017;2017:2439025.
          doi: 10.1155/2017/2439025pubmed: 28596790google scholar: lookup
        8. Schoster A, Staempfli HR, Abrahams M, Jalali M, Weese JS, Guardabassi L. Effect of a probiotic on prevention of diarrhea and Clostridium difficile and Clostridium perfringens shedding in foals.. J Vet Intern Med 2015 May-Jun;29(3):925-31.
          doi: 10.1111/jvim.12584pubmed: 25903509google scholar: lookup
        9. Schoster A, Weese JS, Guardabassi L. Probiotic use in horses - what is the evidence for their clinical efficacy?. J Vet Intern Med 2014 Nov-Dec;28(6):1640-52.
          doi: 10.1111/jvim.12451pubmed: 25231539google scholar: lookup
        10. Endo A, Futagawa-Endo Y, Dicks LM. Lactobacillus and Bifidobacterium diversity in horse feces, revealed by PCR-DGGE.. Curr Microbiol 2009 Dec;59(6):651-5.
          doi: 10.1007/s00284-009-9498-4pubmed: 19730939google scholar: lookup
        11. Ewaschuk JB, Naylor JM, Chirino-Trejo M, Zello GA. Lactobacillus rhamnosus strain GG is a potential probiotic for calves.. Can J Vet Res 2004 Oct;68(4):249-53.
          pubmed: 15581218
        12. Weese JS. Evaluation of deficiencies in labeling of commercial probiotics.. Can Vet J 2003 Dec;44(12):982-3.
          pubmed: 14703084